Vertex Pharmaceuticals | VRTX - Ebitda





Ebitda Changement Date
AbbVie USD 3.69B 1.68B 2026-03
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Amgen USD 3.86B 1.28B 2026-03
Arrowhead Research USD -147.68M 40.33M 2026-06
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Gilead Sciences USD -9.31B 12.82B 2026-06
Incyte USD 778.57M 410.6M 2026-06
Insmed USD 12.73M 161.04M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
J&J USD 8.99B 721M 2026-06
Merck USD -1.54B 7.84B 2026-03
Moderna USD -1.26B 468M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Pfizer USD 6.01B 18M 2026-06
PTC Therapeutics USD 161.9M 99.92M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
United Therapeutics USD 355M 11.1M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06